Effect of ABO blood group incompatibility on the outcome of single-unit cord blood transplantation after myeloablative conditioning

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 4, 2014, Pages 577-581

  Konuma, Takaaki ^a   Kato, Seiko ^a   Ooi, Jun ^b   Oiwa Monna, Maki ^a   Ebihara, Yasuhiro ^a   Mochizuki, Shinji ^a   Yuji, Koichiro ^a   Ohno, Nobuhiro ^a   Kawamata, Toyotaka ^a   Jo, Norihide ^a   Yokoyama, Kazuaki ^a   Uchimaru, Kaoru ^a   Tojo, Arinobu ^a   Takahashi, Satoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ABO incompatibility; Cord blood transplantation; Graft versus host disease; Myeloablative conditioning

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CANCER SURVIVAL; CORD BLOOD STEM CELL TRANSPLANTATION; ENGRAFTMENT; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RETROSPECTIVE STUDY; YOUNG ADULT;

ABO INCOMPATIBILITY; CORD BLOOD TRANSPLANTATION; GRAFT-VERSUS-HOST DISEASE; MYELOABLATIVE CONDITIONING;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; BLOOD GROUP INCOMPATIBILITY; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; UNRELATED DONORS;

EID: 84895781599     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.12.563     Document Type: Article

References (19)

1. Booth G.S., Gehrie E.A., Bolan C.D., Savani B.N. Clinical guide to ABO-incompatible allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2013, 19:1152-1158.
2. Rowley S.D., Donato M.L., Bhattacharyya P. Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation. Bone Marrow Transplant 2011, 46:1167-1185.
3. Seebach J.D., Stussi G., Passweg J.R., et al. ABO blood group barrier in allogeneic bone marrow transplantation revisited. Biol Blood Marrow Transplant 2005, 11:1006-1013.
4. Kimura F., Sato K., Kobayashi S., et al. Impact of ABO-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program. Haematologica 2008, 93:1686-1693.
5. Bacigalupo A., Van Lint M.T., Occhini D., et al. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation 1988, 45:1091-1094.
6. Tomonari A., Takahashi S., Ooi J., et al. Impact of ABO incompatibility on engraftment and transfusion requirement after unrelated cord blood transplantation: a single institute experience in Japan. Bone Marrow Transplant 2007, 40:523-528.
7. Takahashi S., Iseki T., Ooi J., et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 2004, 104:3813-3820.
8. Takahashi S., Ooi J., Tomonari A., et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood 2007, 109:1322-1330.
9. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
10. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980, 69:204-217.
11. Kanda Y. Investigation of the freely available easy-to-use software "EZR" for medical statistics. Bone Marrow Transplant 2013, 48:452-458.
12. Igarashi A., Kakihana K., Haraguchi K., et al. Anti-host isohemagglutinin production is associated with a higher risk of acute GVHD in ABO-incompatible transplantation. Bone Marrow Transplant 2012, 47:1356-1360.
13. Snell M., Chau C., Hendrix D., et al. Lack of isohemagglutinin production following minor ABO incompatible unrelated HLA mismatched umbilical cord blood transplantation. Bone Marrow Transplant 2006, 38:135-140.
14. Romee R., Weisdorf D.J., Brunstein C., et al. Impact of ABO-mismatch on risk of GVHD after umbilical cord blood transplantation. Bone Marrow Transplant 2013, 48:1046-1049.
15. Berglund S., Le Blanc K., Remberger M., et al. Factors with an impact on chimerism development and long-term survival after umbilical cord blood transplantation. Transplantation 2012, 94:1066-1074.
16. Arcese W., Rocha V., Labopin M., et al. Unrelated cord blood transplants in adults with hematologic malignancies. Haematologica 2006, 91:223-230.
17. Narimatsu H., Miyakoshi S., Yamaguchi T., et al. Chronic graft-versus-host disease following umbilical cord blood transplantation: retrospective survey involving 1072 patients in Japan. Blood 2008, 112:2579-2582.
18. Cohen Y.C., Scaradavou A., Stevens C.E., et al. Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. Bone Marrow Transplant 2011, 46:70-76.
19. Blin N., Traineau R., Houssin S., et al. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according tostem cell source. Biol Blood Marrow Transplant 2010, 16:1315-1323.